Related Experiment Videos
[Hypocholesterolemia in hematologic neoplasms]
M Aixalá1, C N Sarandría, J G Speroni
1Departamento de Apoyo Médico, Academia Nacional de Buenos Aires, Argentina.
Sangre
|February 1, 1997
Summary
Cholesterol levels and apolipoproteins are significantly lower in oncohaematologic patients. These lipid markers may aid in diagnosing cancers and understanding tumoral cell metabolism.
Area of Science:
- Biochemistry
- Oncology
- Clinical Chemistry
Context:
- Epidemiological studies link low blood cholesterol to increased cancer mortality risk.
- Oncohaematologic conditions, including various leukemias and lymphomas, are associated with altered lipid profiles.
Purpose:
- To evaluate cholesterol metabolism in oncohaematologic patients.
- To assess the utility of cholesterol, its fractions, and apolipoproteins as biochemical markers in cancer diagnosis.
Summary:
- A study compared lipid profiles (total cholesterol, HDL, LDL, apolipoproteins A1 and B) in 37 oncohaematologic patients and 32 healthy controls.
- Significantly lower total cholesterol, HDL cholesterol, and apolipoprotein A1 were observed in the patient group, particularly with elevated leukocyte counts.
- Myeloma patients exhibited the lowest total cholesterol values.
Impact:
- Cholesterol, its fractions, and apolipoproteins may serve as valuable biochemical markers during cancer diagnosis.
- Understanding lipid metabolism alterations can provide insights into tumoral cell biology and cancer progression.